Phase II, open label, international, multicentre clinical trial to investigate safety and efficacy of oral ITF2357 in patients with active systemic onset juvenile idiopathic arthritis (SOJIA).

Trial Profile

Phase II, open label, international, multicentre clinical trial to investigate safety and efficacy of oral ITF2357 in patients with active systemic onset juvenile idiopathic arthritis (SOJIA).

Completed
Phase of Trial: Phase II

Latest Information Update: 23 May 2013

At a glance

  • Drugs Givinostat (Primary)
  • Indications Juvenile rheumatoid arthritis
  • Focus Adverse reactions
  • Sponsors Italfarmaco
  • Most Recent Events

    • 31 Jan 2012 Actual patient number 17 added as reported by ClinicalTrials.gov.
    • 31 Jan 2012 Actual end date changed from Jun 2008 to Aug 2009 as reported by ClinicalTrials.gov.
    • 14 Nov 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov. Actual completion date reported as June 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top